Home » Newsletters » BioWorld Asia

BioWorld Asia

Nov. 14, 2001

View Archived Issues

Vernalis, Elan Gain Approval In U.S. To Sell Migraine Drug

Mitochondrial DNA Illuminates The Path Of the Body Of St. Luke

Lorantis Adds To Second Round, Closes Financing At #16.2M

Germany Grants Researchers EUR10.8M For Proteome Work

Glycominds Raises $7.1M To Advance Program In Glycans

UK Industry Association Sets Up Task Force On Terrorism

CeNeS Closing U.S. Subsidiary In Another Move To Save Money

Other News To Note

Cerep, Sepracor Enter 5-Year Agreement Around BioPrint

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...